Published in Brain Res Bull on September 15, 2001
The corticostriatal pathway in Huntington's disease. Prog Neurobiol (2006) 1.99
The use of the R6 transgenic mouse models of Huntington's disease in attempts to develop novel therapeutic strategies. NeuroRx (2005) 1.33
Alterations in cortical excitation and inhibition in genetic mouse models of Huntington's disease. J Neurosci (2009) 1.28
Dysregulation of intracellular dopamine stores revealed in the R6/2 mouse striatum. J Neurochem (2009) 1.10
Aging alters the expression of neurotransmission-regulating proteins in the hippocampal synaptoproteome. J Neurochem (2010) 1.08
Role of ubiquitin-proteasome-mediated proteolysis in nervous system disease. Biochim Biophys Acta (2010) 1.01
Distinct isoforms of the RFX transcription factor DAF-19 regulate ciliogenesis and maintenance of synaptic activity. Mol Biol Cell (2008) 0.99
Cytotoxicity of botulinum neurotoxins reveals a direct role of syntaxin 1 and SNAP-25 in neuron survival. Nat Commun (2013) 0.99
Genetics and neuropathology of Huntington's disease. Int Rev Neurobiol (2011) 0.99
Tensor-based morphometry and stereology reveal brain pathology in the complexin1 knockout mouse. PLoS One (2012) 0.96
Motifs and cis-regulatory modules mediating the expression of genes co-expressed in presynaptic neurons. Genome Biol (2009) 0.90
Corticostriatal circuit dysfunction in Huntington's disease: intersection of glutamate, dopamine and calcium. Future Neurol (2010) 0.89
In vivo Dopamine Efflux is Decreased in Striatum of both Fragment (R6/2) and Full-Length (YAC128) Transgenic Mouse Models of Huntington's Disease. Front Syst Neurosci (2011) 0.88
Myosin motor proteins are involved in the final stages of the secretory pathways. Biochem Soc Trans (2011) 0.88
Is synaptic loss a unique hallmark of Alzheimer's disease? Biochem Pharmacol (2014) 0.87
Disruption of Purkinje cell function prior to huntingtin accumulation and cell loss in an animal model of Huntington disease. Exp Neurol (2012) 0.84
Purkinje cell dysfunction and loss in a knock-in mouse model of Huntington disease. Exp Neurol (2012) 0.83
N-ethylmaleimide-sensitive factor attachment protein α (αSNAP) regulates matrix adhesion and integrin processing in human epithelial cells. J Biol Chem (2013) 0.77
Calcium Handling by Endoplasmic Reticulum and Mitochondria in a Cell Model of Huntington's Disease. PLoS Curr (2016) 0.75
Transcriptome analyses identify key cellular factors associated with HIV-1-associated neuropathogenesis in infected men. AIDS (2017) 0.75
Synaptic Vesicle-Recycling Machinery Components as Potential Therapeutic Targets. Pharmacol Rev (2017) 0.75
Depressed Synaptic Transmission and Reduced Vesicle Release Sites in Huntington's Disease Neuromuscular Junctions. J Neurosci (2017) 0.75
The organization of the projection from the cerebral cortex to the striatum in the rat. Neuroscience (1989) 3.57
Cannabinoid receptors in the human brain: a detailed anatomical and quantitative autoradiographic study in the fetal, neonatal and adult human brain. Neuroscience (1997) 2.56
Brain-derived neurotrophic factor is reduced in Alzheimer's disease. Brain Res Mol Brain Res (1997) 2.08
A novel function for the second C2 domain of synaptotagmin. Ca2+-triggered dimerization. J Biol Chem (1996) 1.82
Structure of Ocr from bacteriophage T7, a protein that mimics B-form DNA. Mol Cell (2002) 1.73
Neuroprotective effects of adenosine. Trends Pharmacol Sci (1988) 1.69
Endocytosis and recycling of G protein-coupled receptors. Trends Pharmacol Sci (1997) 1.65
A cell-free system for regulated exocytosis in PC12 cells. J Cell Biol (2000) 1.60
Comparative distribution of voltage-gated sodium channel proteins in human brain. Brain Res Mol Brain Res (2001) 1.60
Efferent connections and nigral afferents of the nucleus accumbens septi in the rat. Neuroscience (1978) 1.57
The pattern of neurodegeneration in Huntington's disease: a comparative study of cannabinoid, dopamine, adenosine and GABA(A) receptor alterations in the human basal ganglia in Huntington's disease. Neuroscience (2000) 1.55
Comparative proteome analysis of the hippocampus implicates chromosome 6q in schizophrenia. Mol Psychiatry (2000) 1.54
Direct observation of DNA translocation and cleavage by the EcoKI endonuclease using atomic force microscopy. Nat Struct Biol (1999) 1.35
Distribution of voltage-gated sodium channel alpha-subunit and beta-subunit mRNAs in human hippocampal formation, cortex, and cerebellum. J Comp Neurol (2000) 1.34
Decreased neuronal nitric oxide synthase messenger RNA and somatostatin messenger RNA in the striatum of Huntington's disease. Neuroscience (1996) 1.30
Identification of SNAREs involved in regulated exocytosis in the pancreatic acinar cell. J Biol Chem (1999) 1.27
Dopamine D1 and D2 receptor gene expression in the striatum in Huntington's disease. Ann Neurol (1997) 1.18
A specific interaction in vitro between pancreatic zymogen granules and plasma membranes: stimulation by G-protein activators but not by Ca2+. J Cell Biol (1989) 1.15
In situ evidence for DNA fragmentation in Huntington's disease striatum and Alzheimer's disease temporal lobes. Neuroreport (1995) 1.12
Insulin-like growth factor-1 reduces postischemic white matter injury in fetal sheep. J Cereb Blood Flow Metab (2001) 1.12
D2 dopamine receptor antagonists induce fos and related proteins in rat striatal neurons. Neuroscience (1990) 1.09
Changes in the mRNAs encoding voltage-gated sodium channel types II and III in human epileptic hippocampus. Neuroscience (2001) 1.06
The organization and collateralization of corticostriate neurones in the motor and sensory cortex of the rat brain. Brain Res (1987) 1.05
A cell-free assay for the insertion of a viral glycoprotein into the plasma membrane. J Cell Biol (1986) 1.04
Proteomic analysis of the brain in Alzheimer's disease: molecular phenotype of a complex disease process. Proteomics (2001) 1.03
Effects of the immunosuppressants cyclosporin A and FK 506 on exocytosis in the rat exocrine pancreas in vitro. Br J Pharmacol (1993) 1.02
Characterization of [(3)H]Quisqualate binding to recombinant rat metabotropic glutamate 1a and 5a receptors and to rat and human brain sections. J Neurochem (2000) 1.02
Translocation-independent dimerization of the EcoKI endonuclease visualized by atomic force microscopy. Biophys J (2000) 1.02
Neuroprotective strategies for basal ganglia degeneration: Parkinson's and Huntington's diseases. Prog Neurobiol (2000) 1.01
Trinucleotide (CAG) repeat length is positively correlated with the degree of DNA fragmentation in Huntington's disease striatum. Neuroscience (1998) 1.01
N-terminal tripeptide of IGF-1 (GPE) prevents the loss of TH positive neurons after 6-OHDA induced nigral lesion in rats. Brain Res (2000) 1.01
Loss of A1 adenosine receptors in human temporal lobe epilepsy. Brain Res (1996) 1.00
Connexin expression in Huntington's diseased human brain. Cell Biol Int (1998) 1.00
Reduction in enkephalin and substance P messenger RNA in the striatum of early grade Huntington's disease: a detailed cellular in situ hybridization study. Neuroscience (1996) 1.00
Amyloid-like inclusions in Huntington's disease. Neuroscience (2000) 0.99
Reconstitution of regulated exocytosis in cell-free systems: a critical appraisal. Annu Rev Physiol (1999) 0.98
Gene expression of PSD95 in prefrontal cortex and hippocampus in schizophrenia. Neuroreport (2000) 0.98
GABA(B) receptor heterodimer-component localisation in human brain. Brain Res Mol Brain Res (2000) 0.97
Alzheimer's disease: changes in hippocampal N-methyl-D-aspartate, quisqualate, neurotensin, adenosine, benzodiazepine, serotonin and opioid receptors--an autoradiographic study. Neuroscience (1990) 0.96
Somatostatin receptors in Neuro2A neuroblastoma cells: ligand internalization. Br J Pharmacol (1997) 0.96
Analysis of the association of syncollin with the membrane of the pancreatic zymogen granule. J Biol Chem (2000) 0.95
Expression of the glutamate transporters in human temporal lobe epilepsy. Neuroscience (1999) 0.94
Long-term potentiation and the induction of c-fos mRNA and proteins in the dentate gyrus of unanesthetized rats. Neurosci Lett (1989) 0.94
Changes in dopamine levels in the corpus striatum following lesions in the substantia nigra. Exp Neurol (1969) 0.94
Gene expression of metabotropic glutamate receptor 5 and excitatory amino acid transporter 2 in the schizophrenic hippocampus. Brain Res Mol Brain Res (2000) 0.93
Intracellular trafficking of the muscarinic acetylcholine receptor: importance of subtype and cell type. Mol Pharmacol (1996) 0.93
The distribution of calbindin, calretinin and parvalbumin immunoreactivity in the human thalamus. J Chem Neuroanat (2000) 0.92
Targeting of the zymogen-granule protein syncollin in AR42J and AtT-20 cells. Biochem J (2000) 0.92
Fusion between rat pancreatic zymogen granules and plasma membranes. Modulation by a GTP-binding protein. Biochem J (1992) 0.92
Progressive depletion of complexin II in a transgenic mouse model of Huntington's disease. J Neurochem (2001) 0.92
Cholesterol-dependent interaction of syncollin with the membrane of the pancreatic zymogen granule. Biochem J (2001) 0.92
Syntaxin is efficiently excluded from sphingomyelin-enriched domains in supported lipid bilayers containing cholesterol. J Membr Biol (2003) 0.92
Muscarinic cholinergic receptors in the human spinal cord: differential localization of [3H]pirenzepine and [3H]quinuclidinylbenzilate binding sites. Brain Res (1985) 0.91
Loss of sigma binding sites in the CA1 area of the anterior hippocampus in Alzheimer's disease correlates with CA1 pyramidal cell loss. Brain Res (1993) 0.91
XCE, a new member of the endothelin-converting enzyme and neutral endopeptidase family, is preferentially expressed in the CNS. Brain Res Mol Brain Res (1999) 0.91
Opiate receptors in the human spinal cord: a detailed anatomical study comparing the autoradiographic localization of [3H]diprenorphine binding sites with the laminar pattern of substance P, myelin and nissl staining. Neuroscience (1987) 0.90
3-Nitropropionic acid's lethal triplet: cooperative pathways of neurodegeneration. Neuroreport (1998) 0.90
Bax expression in mammalian neurons undergoing apoptosis, and in Alzheimer's disease hippocampus. Brain Res (1997) 0.89
Repeated asphyxia causes loss of striatal projection neurons in the fetal sheep brain. Neuroscience (1995) 0.89
GABA, GABA receptors and benzodiazepine receptors in the human spinal cord: an autoradiographic and immunohistochemical study at the light and electron microscopic levels. Neuroscience (1990) 0.89
Loss of cannabinoid receptors in the substantia nigra in Huntington's disease. Neuroscience (1993) 0.89
Autoradiographic localisation of NMDA, quisqualate and kainic acid receptors in human spinal cord. Neurosci Lett (1990) 0.89
Fates of endocytosed somatostatin sst2 receptors and associated agonists. Biochem J (1998) 0.89
DNA translocation by type III restriction enzymes: a comparison of current models of their operation derived from ensemble and single-molecule measurements. Nucleic Acids Res (2011) 0.89
A comparative proteome analysis of hippocampal tissue from schizophrenic and Alzheimer's disease individuals. Mol Psychiatry (1999) 0.88
Trk receptor alterations in Alzheimer's disease. Brain Res Mol Brain Res (1996) 0.88
Effect of G protein-coupled receptor kinase 2 on the sensitivity of M4 muscarinic acetylcholine receptors to agonist-induced internalization and desensitization in NG108-15 cells. J Neurochem (1999) 0.87
Kinetic analysis of the trafficking of muscarinic acetylcholine receptors between the plasma membrane and intracellular compartments. J Biol Chem (1994) 0.87
The visual cortico-striato-nigral pathway in the rat. Neuroscience (1986) 0.87
Stimulation of exocytotic membrane fusion by modified peptides of the rab3 effector domain: re-evaluation of the role of rab3 in regulated exocytosis. Biochem J (1993) 0.87
P2X4 receptors interact with both P2X2 and P2X7 receptors in the form of homotrimers. Br J Pharmacol (2011) 0.86
Localization of calcium-binding proteins and GABA transporter (GAT-1) messenger RNA in the human subthalamic nucleus. Neuroscience (1999) 0.86
Real-time studies of zymogen granule exocytosis in intact rat pancreatic acinar cells. J Physiol (2000) 0.86
Diagnosis of mitochondrial disease: assessment of mitochondrial DNA heteroplasmy in blood. Biochem Biophys Res Commun (1998) 0.86
Involvement of a phosphoprotein on the zymogen granule membrane in the control of regulated exocytosis in the exocrine pancreas. J Cell Sci (1993) 0.86
Expression of Fos, Jun, and Krox family proteins in Alzheimer's disease. Exp Neurol (1997) 0.86
Benzodiazepine receptors in the human spinal cord: a detailed anatomical and pharmacological study. Neuroscience (1986) 0.85
Syncollin homo-oligomers associate with lipid bilayers in the form of doughnut-shaped structures. J Membr Biol (2002) 0.85
Induction of c-fos mRNA and protein in neurons and glia after traumatic brain injury: pharmacological characterization. Exp Neurol (1990) 0.85
Cloning and functional expression of alternative spliced variants of the human metabotropic glutamate receptor 8. Brain Res Mol Brain Res (1999) 0.85
The relationship between agonist intrinsic activity and the rate of endocytosis of muscarinic receptors in a human neuroblastoma cell line. Mol Pharmacol (1998) 0.84
The effects of the N-terminal tripeptide of insulin-like growth factor-1, glycine-proline-glutamate in different regions following hypoxic-ischemic brain injury in adult rats. Neuroscience (1999) 0.84
Effects of monensin on the processing and intracellular transport of influenza virus haemagglutinin in infected MDCK cells. J Cell Sci (1984) 0.84
A comparative study of the neurons of origin of the spinocerebellar afferents in the rat, cat and squirrel monkey based on the retrograde transport of horseradish peroxidase. J Comp Neurol (1978) 0.84
Selective neuroprotective effects with insulin-like growth factor-1 in phenotypic striatal neurons following ischemic brain injury in fetal sheep. Neuroscience (2000) 0.83
Regional and cellular localisation of GABA(A) receptor subunits in the human basal ganglia: An autoradiographic and immunohistochemical study. J Comp Neurol (1999) 0.82
Estimation of the density of sodium entry sites in frog skin epithelium from the uptake of [3H]benzamil. J Physiol (1979) 0.82
Kinetics of amiloride action in the hen coprodaeum in vitro. Pflugers Arch (1982) 0.82
Neuroprotective effects of Gly-Pro-Glu, the N-terminal tripeptide of IGF-1, in the hippocampus in vitro. Neuroreport (1999) 0.82
Proteome map of the human hippocampus. Hippocampus (1999) 0.82
Excitatory amino acid receptors in the human cerebral cortex: a quantitative autoradiographic study comparing the distributions of [3H]TCP, [3H]glycine, L-[3H]glutamate, [3H]AMPA and [3H]kainic acid binding sites. Neuroscience (1989) 0.82
A monoclonal antibody to rabbit brain GABA transaminase. J Neurochem (1985) 0.82
Immediate-early genes, kindling and long-term potentiation. Neurosci Biobehav Rev (1989) 0.81
Differential recognition of secretory vesicles by annexins. European Molecular Biology Organization Course "Advanced Techniques for Studying Secretion". Biochem Biophys Res Commun (1992) 0.81
MK801 induces c-fos protein in thalamic and neocortical neurons of rat brain. Neurosci Lett (1990) 0.81
MK-801 induces c-fos protein in thalamic and neocortical neurons of rat brain. Neurosci Lett (1990) 0.81
The neuroprotective actions of a calcium channel antagonist, flunarizine, in the infant rat. Pediatr Res (1989) 0.81
Localisation of the adenosine uptake site in the human brain: a comparison with the distribution of adenosine A1 receptors. Brain Res (1996) 0.80
Trafficking of green fluorescent protein-tagged muscarinic M4 receptors in NG108-15 cells. Eur J Pharmacol (2001) 0.80